MRx0518 in Patients With Solid Tumours Waiting Surgical Removal of the Tumour
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Melanoma|Breast Cancer|Uterine Cancer|Ovarian Cancer|Prostate Cancer|Urethral Cancer|Bladder Cancer|Renal Cancer|Lung Cancer|Head and Neck Cancer
Interventions: DRUG: MRx0518 Capsules|DRUG: MRx0518/placebo Capsules
Sponsor: Imperial College London
Collaborators: 4D pharma plc